Free PA MPJE Exam Flashcards

Pennsylvania requires a passing NAPLEX score and a passing Pennsylvania MPJE score for pharmacist licensure by examination.

The Board lists graduation from an ACPE-accredited PharmD or BS in pharmacy as an examination pathway requirement, subject to the Board's current instructions.

A foreign graduate follows the Board's applicable pathway, which includes the Foreign Pharmacy Graduate Examination Committee (FPGEC) certification requirement listed by the Board.

Licensure by examination requires 1,500 acceptable intern hours. Confirm how hours are documented and accepted with the Pennsylvania Board.

The Board lists a 3-hour approved child-abuse-recognition training for initial pharmacist licensure, to be completed within the first year of licensure.

The Board lists 4 hours of approved pain-management, controlled-substance, or opioid education within the first year: 2 hours on pain/addiction and 2 hours on prescribing or dispensing opioids.

A pharmacist must complete 30 contact hours of continuing education for each biennial renewal period, including 2 hours of child-abuse recognition and reporting training.

A pharmacist may delegate permitted parts of professional practice to an intern, technician, or technician trainee only under the conditions in Pennsylvania law.

Pennsylvania requires the pharmacist to review every prescription or drug order before it is dispensed, including work performed through permitted delegation.

When delegation is permitted, the pharmacist must provide direct, immediate personal supervision as required by Pennsylvania Code §27.12.

Only a pharmacist may provide the counseling required by Pennsylvania Code §27.19; delegated personnel cannot replace pharmacist counseling.

Before dispensing, verify that the prescription is issued by a practitioner authorized to prescribe the drug and acting within the practitioner's authorized scope.

For a controlled-substance prescription, the pharmacist's record must include the prescriber's DEA registration number when required by Pennsylvania Code §27.18.

An electronic controlled-substance prescription is treated as written only when it meets applicable federal and Pennsylvania law requirements; retain the required electronic-record information.

A Schedule II prescription may not be refilled under Pennsylvania Code §27.18. Treat a new authorized prescription as distinct from a refill.

Pennsylvania Code §27.18 provides that a Schedule II prescription may not be filled more than 6 months after its issue date.

A Schedule III, IV, or V prescription may be refilled no more than 5 times within 6 months after the issue date under Pennsylvania Code §27.18.

A nonproprietary prescription may not be refilled more than 1 year after the date it was issued unless a new authorization is obtained.

A prescription may not be refilled after the prescriber dies. Obtain a new authorized prescription rather than treating it as a refill.

Offer counseling to the patient or caregiver for every new retail or outpatient prescription. A patient or caregiver may refuse the offer.

When counseling is accepted in person, the pharmacist provides oral counseling, except where the regulation permits written information based on professional judgment.

For a prescription delivered to the patient, make a reasonable effort to provide pharmacist counseling and a method for the patient or caregiver to obtain it.

A patient or caregiver may refuse counseling. The pharmacist must make the required offer; refusal does not authorize another staff member to give pharmacist counseling.

A patient profile supports safe pharmacy care by organizing relevant medication information for review, counseling, and prospective drug-use review.

Use and disclose patient information only as authorized by law and necessary for care, payment, operations, or another permitted purpose; protect it from inappropriate access.

A pharmacist may decline to fill a prescription believed to be false, fraudulent, unlawful, for diversion or misuse, or unsafe, and must explain the decision to the patient or caregiver.

If necessary to resolve a safety or validity concern, discuss the prescription with the prescriber before deciding whether it can be dispensed.

Apply the prevailing law of the jurisdiction of licensure. NABP does not label MPJE questions as federal-law or state-law questions.

A controlled-substance prescription must be issued for a legitimate medical purpose by a practitioner acting in the usual course of professional practice; resolve red flags before dispensing.

Before dispensing, use the available patient and prescription information to identify potential medication-related problems and intervene when appropriate.

Dispensers must report each Schedule II, III, IV, and V controlled-substance dispensing to the Pennsylvania PDMP, including a zero report when no reportable dispensing occurred.

Report controlled-substance dispensing to the Pennsylvania PDMP no later than the close of the next business day after dispensing.

A dispenser must query the PDMP before dispensing an opioid or benzodiazepine to a new patient, subject to statutory exceptions.

A dispenser must query the PDMP before dispensing an opioid or benzodiazepine when the patient seeks an early refill, subject to statutory exceptions.

A dispenser must query the PDMP before dispensing an opioid or benzodiazepine when the patient pays cash after the dispenser knows the patient has third-party coverage, subject to statutory exceptions.

A dispenser must query the PDMP before dispensing an opioid or benzodiazepine when the patient obtains either drug from more than one prescriber, subject to statutory exceptions.

A dispensed prescription label includes the pharmacy's name, address, and telephone number; patient name; prescriber name; serial number; and date of filling.

The label includes directions for use and the drug's brand or trade name, strength, dosage form, and quantity. A generically substituted product also identifies its manufacturer.

A controlled-substance prescription container must bear the federal transfer warning required by Pennsylvania Code §27.18.

Dispense a new prescription in a clean container or the original manufacturer's container. A refill may use a clean, reusable container with a new label.

A computerized system must allow immediate retrieval of required prescription information for at least 12 months after the last activity on the record.

For the next 24 months after the immediate-retrieval period, required prescription information must be retrievable within 3 working days.

Keep the original prescription or its permitted image for at least 2 years from the date of the last filling, unless another applicable law requires a longer period.

Inventory and recordkeeping support accountability for controlled substances, help detect diversion, and allow regulators to verify lawful acquisition, storage, and distribution.

Store controlled substances to prevent unauthorized access, loss, theft, or diversion, and follow the applicable federal and Pennsylvania security requirements.

Compound only within applicable law and the pharmacy's policies, using appropriate ingredients, records, quality controls, storage, and labeling for the preparation.

When a central-fill arrangement is permitted, clearly assign pharmacist responsibilities and preserve the records, labeling, patient-safety checks, and legal controls required for dispensing.

When selecting a product, confirm that any substitution is legally permitted, clinically appropriate, accurately labeled, and documented as required.

They standardize safe, lawful work for ordering, storage, dispensing, compounding, delivery, records, and response to medication errors or diversion concerns.

An inspection evaluates whether the pharmacy's premises, personnel, drugs, records, and operating practices comply with pharmacy law and protect the public.